{"title":"A comprehensive review on the cellular mechanism of traditional Chinese medicine in the treatment of pediatric lung diseases.","authors":"Yanhao Wang","doi":"10.34172/bi.30945","DOIUrl":null,"url":null,"abstract":"<p><p>Numerous researchers have examined the environmental and regional characteristics, as well as the mother's dwelling air quality during pregnancy, that influence children's lung disease. The most common type of medicine is Western medicine, however Chinese medicine is more effective at treating lung conditions in youngsters. The common cold, pneumonia, bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are among the respiratory ailments that traditional Chinese medicine (TCM) is frequently used to treat. TCM has qualities like resolving a variety of issues, focusing on several areas, and reducing harmful side effects. TCM has justified its anti-asthma, bronchiolitis, and pulmonary fibrosis (PF) effect in clinical practice but its underlying mechanism and specific role in mentioned disease are still unknown. According to some animal research, the traditional recipe, precise measurements, and organic substances extracted from TCM could considerably reduce changes in the structure of the airways and show anti-inflammatory properties. By examining these results and information, we will talk about the potential Patho mechanism that underlies asthmatic airway inflammation and remodeling as well as the special function of TCM in asthma treatment by controlling various signaling pathways. We provide a summary of the developments in research on TCM extracts for the treatment of asthma, bronchiolitis, PF, and lung cancer in this review paper. Additionally, we shall discuss a few cellular aspects.</p>","PeriodicalId":48614,"journal":{"name":"Bioimpacts","volume":"15 ","pages":"30945"},"PeriodicalIF":2.2000,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12204816/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioimpacts","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.34172/bi.30945","RegionNum":4,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Numerous researchers have examined the environmental and regional characteristics, as well as the mother's dwelling air quality during pregnancy, that influence children's lung disease. The most common type of medicine is Western medicine, however Chinese medicine is more effective at treating lung conditions in youngsters. The common cold, pneumonia, bronchitis, asthma, chronic obstructive pulmonary disease (COPD), and lung cancer are among the respiratory ailments that traditional Chinese medicine (TCM) is frequently used to treat. TCM has qualities like resolving a variety of issues, focusing on several areas, and reducing harmful side effects. TCM has justified its anti-asthma, bronchiolitis, and pulmonary fibrosis (PF) effect in clinical practice but its underlying mechanism and specific role in mentioned disease are still unknown. According to some animal research, the traditional recipe, precise measurements, and organic substances extracted from TCM could considerably reduce changes in the structure of the airways and show anti-inflammatory properties. By examining these results and information, we will talk about the potential Patho mechanism that underlies asthmatic airway inflammation and remodeling as well as the special function of TCM in asthma treatment by controlling various signaling pathways. We provide a summary of the developments in research on TCM extracts for the treatment of asthma, bronchiolitis, PF, and lung cancer in this review paper. Additionally, we shall discuss a few cellular aspects.
BioimpactsPharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.80
自引率
7.70%
发文量
36
审稿时长
5 weeks
期刊介绍:
BioImpacts (BI) is a peer-reviewed multidisciplinary international journal, covering original research articles, reviews, commentaries, hypotheses, methodologies, and visions/reflections dealing with all aspects of biological and biomedical researches at molecular, cellular, functional and translational dimensions.